curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer

by palligoelme@gmail.com | May 8, 2025 | Clinical Trials

​ Conditions: Breast Cancer; Invasive Carcinoma of Breast; Ductal Breast Carcinoma in Situ Interventions: Radiation: Radiation Therapy Sponsors: University of Utah Not yet recruiting Conditions: Breast Cancer; Invasive Carcinoma of Breast; Ductal Breast Carcinoma in...

A Novel Method for Determination of Thromboembolic Stroke Origin

by palligoelme@gmail.com | May 8, 2025 | Clinical Trials

​ Conditions: Thromboembolic Stroke Interventions: Drug: NaF PET-CT Sponsors: Atlantic Health System Not yet recruiting Conditions: Thromboembolic Stroke Interventions: Drug: NaF PET-CT Sponsors: Atlantic Health System Not yet...

Comparative Study and Validation of New Methodologies for Measuring Addition

by palligoelme@gmail.com | May 8, 2025 | Clinical Trials

​ Conditions: Presbyopia; Near Vision; Refraction Error Interventions: Device: Visual Acuity; Device: Objective refraction; Device: Standard Subjective refraction; Device: Near vision examination and determination of additions; Device: Binocular vision tests; Device:...

Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa

by palligoelme@gmail.com | May 7, 2025 | Clinical Trials

​ Conditions: Hidradenitis Suppurativa (HS) Interventions: Device: Nd:YAG Laser; Device: Alexandrite Laser Sponsors: Geisinger Clinic Not yet recruiting Conditions: Hidradenitis Suppurativa (HS) Interventions: Device: Nd:YAG Laser; Device: Alexandrite Laser Sponsors:...

Base Editing Hematopoietic Stem Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study

by palligoelme@gmail.com | May 7, 2025 | Clinical Trials

​ Conditions: CD40L-HyperIgM Syndrome Interventions: Drug: Busulfan; Drug: Palifermin; Drug: Sirolimus; Drug: Alemtuzumab; Biological: Base-edited hematopoietic stem and progenitor cells Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Enrolling...
« Older Entries
Next Entries »

Recent Posts

  • Gait Adaptability in Persons With MS Having Mild Disability
  • Comparative Study of Non-surgical Hearing Devices Based on Bone Conduction
  • Heterogeneity of Oral Carcinogenesis: From PrEneoplasia to Invasive Squamous Cell Carcinoma
  • Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)
  • Sex-Based Disparities in the Electrophysiological Substrate for Atrial Fibrillation and Its Impact on Clinical Outcomes

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®